FDA applicant
Medexel Co.,Ltd
FDA records 3 decisions for Medexel Co.,Ltd (Anseong-Si, KR) from 2016 to 2024: 3 510(k) clearances. Most are in product codes FMI (Needle, Hypodermic, Single Lumen) and QNQ (Low Dead Space Piston Syringe). Since 2016 its 510(k)s took a median of 266 days from receipt to decision, against 182 for FDA’s reviews in the same codes and years. Its devices cite 2 predicates, 0 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Medexel Co.,Ltd’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2016.
Planning a device like Medexel Co.,Ltd’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Medexel”
FDA records each applicant name separately; these may or may not be the same firm.